These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10561375)

  • 41. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Myelofibrosis: A Moving Target.
    Cerquozzi S; Farhadfar N; Tefferi A
    Cancer J; 2016; 22(1):51-61. PubMed ID: 26841017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
    Visani G; Finelli C; Castelli U; Petti MC; Ricci P; Vianelli N; Gianni L; Zuffa E; Aloe Spiriti MA; Latagliata R
    Br J Haematol; 1990 May; 75(1):4-9. PubMed ID: 2375922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract]   [Full Text] [Related]  

  • 45. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
    Thiele J; Steinberg T; Zankovich R; Fischer R
    Anticancer Res; 1989; 9(2):429-35. PubMed ID: 2751268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. bcr/abl-negative, classic myeloproliferative disorders: diagnosis and treatment.
    Tefferi A; Barbui T
    Mayo Clin Proc; 2005 Sep; 80(9):1220-32. PubMed ID: 16178503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allogeneic stem cell transplant vs.Janus kinase inhibition in the treatment of primary myelofibrosis or myelofibrosis after essential thrombocythemia or polycythemia vera.
    Alchalby H; Kröger N
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S36-41. PubMed ID: 25486953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology.
    Eran Z; Zingariello M; Bochicchio MT; Bardelli C; Migliaccio AR
    F1000Res; 2019; 8():. PubMed ID: 31583083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleural fluid extramedullary hematopoiesis case report with review of the literature.
    Koch M; Kurian EM
    Diagn Cytopathol; 2016 Jan; 44(1):41-4. PubMed ID: 26592973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
    Tefferi A; Dingli D; Li CY; Dewald GW
    Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.
    Gianelli U; Iurlo A; Cattaneo D; Lambertenghi-Deliliers G
    Expert Rev Hematol; 2014 Apr; 7(2):255-64. PubMed ID: 24524231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis.
    Kröger N; Zabelina T; Alchalby H; Stübig T; Wolschke C; Ayuk F; von Hünerbein N; Kvasnicka HM; Thiele J; Kreipe HH; Büsche G
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):812-5. PubMed ID: 24589549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Semin Oncol; 2005 Aug; 32(4):403-13. PubMed ID: 16202686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myeloproliferative neoplasms: A decade of discoveries and treatment advances.
    Tefferi A
    Am J Hematol; 2016 Jan; 91(1):50-8. PubMed ID: 26492355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical review of pathogenetic mechanisms in myelofibrosis with myeloid metaplasia.
    Martyré MC
    Curr Hematol Rep; 2003 May; 2(3):257-63. PubMed ID: 12901348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation.
    Stein BL; Moliterno AR
    JAMA; 2010 Jun; 303(24):2513-8. PubMed ID: 20571018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups.
    Cervantes F; Barosi G; Demory JL; Reilly J; Guarnone R; Dupriez B; Pereira A; Montserrat E
    Br J Haematol; 1998 Aug; 102(3):684-90. PubMed ID: 9722294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.